EagleClaw Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
EagleClaw Capital Management's LLY Position: Q2 2026 in Review
EagleClaw Capital Management reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $25.5K and leaving 1,772 shares worth $2.13M. The position accounts for 0.29% of the portfolio, ranked #70.
EagleClaw Capital Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- EagleClaw Capital Management held 1,772 shares of Eli Lilly worth $2.13M as of Q2 2026.
- EagleClaw Capital Management sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
- Eli Lilly made up 0.29% of EagleClaw Capital Management's portfolio in Q2 2026, its #70 holding.
- EagleClaw Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on EagleClaw Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.